🔎 Trials Near Me

홈 › 만성 폐쇄성 폐질환 › 루이지애나

루이지애나의 만성 폐쇄성 폐질환 임상 시험

만성 폐쇄성 폐질환 관련 연구 9개가 루이지애나 내 여러 지역에서 참여자를 모집하고 있습니다.

루이지애나의 도시

공식 연구 텍스트(영어)

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • Southern Clinical Research - Zachary- Site Number : 8400113, Zachary
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07190209

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Care Access - Shreveport - Youree Drive- Site Number : 8400007, Shreveport
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07190222

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

  • GSK Investigational Site, Lake Charles
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07780669

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Zachary
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07082738

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Southern Clinical Research, LLC, Zachary
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07363694

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Lafayette
  • Research Site, Monroe
  • Research Site, Zachary
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06283966

STRIVE Post-Market Registry Study

  • LSU Health Shreveport, Shreveport
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Lake Charles
  • GSK Investigational Site, Shreveport
피험자 모집 중3상
40세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07177339

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Baton Rouge
  • GSK Investigational Site, Lafayette
  • GSK Investigational Site, Shreveport
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT06961214

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.